G-AEP-Kriterien - Deutsche Gesellschaft für Gerontologie und ...

CTG: Kosten, Krankheits-; Krankenhausinfektion/*Ökonomie;
Krankenhausinfektion/Epidemiologie; Arzneimittelkosten; Krankenhausbettenkapazität, 500
und mehr; Krankenhauskosten/*Statistik & Zahlen; Krankenhäuser, Lehr-/Ökonomie;
Mensch; Inzidenz; Krankenhausaufenthaltsdauer/Ökonomie; Methicillinresistenz/*;
Ontario/Epidemiologie; Patientenisolierung/Ökonomie;
Staphylokokkeninfektionen/*Ökonomie; Staphylokokkeninfektionen/Epidemiologie;
Staphylokokkeninfektionen/*Verhütung & Bekämpfung; Staphylococcus
aureus/*Arzneimittelwirkungen
AB: OBJECTIVES: To determine the costs associated with the management of hospitalized
patients with methicillin-resistant Staphylococcus aureus (MRSA), and to estimate the
economic burden associated with MRSA in Canadian hospitals. DESIGN: Patient-specific
costs were used to determine the attributable cost of MRSA associated with excess
hospitalization and concurrent treatment. Excess hospitalization for infected patients was
identified using the Appropriateness Evaluation Protocol, a criterion-based chart review
process to determine the need for each day of hospitalization. Concurrent treatment costs
were identified through chart review for days in isolation, antimicrobial therapy, and MRSA
screening tests. The economic burden to Canadian hospitals was estimated based on
3,167,521 hospital discharges for 1996 and 1997 and an incidence of 4.12 MRSA cases per
1,000 admissions. SETtING: A tertiary-care, university-affiliated teaching hospital in
Toronto, Ontario, Canada. PATIENTS: Inpatients with at least one culture yielding MRSA
between April 1996 and March 1998. RESULTS: A total of 20 patients with MRSA infections
and 79 colonized patients (with 94 admissions) were identified. This represented a rate of
2.9 MRSA cases per 1,000 admissions. The mean number of additional hospital days
attributable to MRSA infection was 14, with 11 admissions having at least 1 attributable day.
The total attributable cost to treat MRSA infections was $287,200, or $14,360 per patient
The cost for isolation and management of colonized patients was $128,095, or $1,363 per
admission. Costs for MRSA screening in the hospital were $109,813. Assuming an infection
rate of 10% to 20%, we determined the costs associated with MRSA in Canadian hospitals
to be $42 million to $59 million annually. CONCLUSIONS: These results indicate that there
is a substantial economic burden associated with MRSA in Canadian hospitals. These costs
will continue to rise if the incidence of MRSA increases further.
4/19 von 41 DIMDI: MEDLINE (ME66) © NLM
ND: 21085874
PMID: 11219403
Autoren: Neumann A; Schultz-Coulon HJ
Titel: Die anwendung des Appropriateness Evaluation Protocol bei HNO-stationärem
Patientengut.
Use of the Appropriateness Evaluation Protocol in inpatient ENT practice
Quelle: HNO; VOL: 49 (1); p. 12-20 /200101/
SU: IM
Sprache: German
CY: Germany
JID: 2985099R
ISSN: 0017-6192
CO: HBZHAS
Institution: Klinik für-Hals -, Nasen, Ohrenheilkunde, Kopf-und Halschirurgie, Plastische Operationen,
Phoniatrie und Pädaudiologie, Lukaskrankenhaus, Städtische Kliniken Neuss.
a.neumann@online-club.de
DT: Journal Article
Schlagwörter
CT: ENGLISH ABSTRACT; GERMANY; HEALTH SERVICES MISUSE/*; HUMAN; LENGTH
OF STAY; OTORHINOLARYNGOLOGIC DISEASES/CLASSIFICATION;
OTORHINOLARYNGOLOGIC DISEASES/*DIAGNOSIS; OTORHINOLARYNGOLOGIC
DISEASES/SURGERY; PATIENT ADMISSION/*; RETROSPECTIVE STUDIES;
UTILIZATION REVIEW
CTG: Englisches Referat; Deutschland; Gesundheitsdienste, Mißbrauch/*; Mensch;
Krankenhausaufenthaltsdauer; Hals-Nasen-Ohren-Krankheiten/Klassifizierung; Hals-
Nasen-Ohren-Krankheiten/*Diagnose; Hals-Nasen-Ohren-Krankheiten/Chirurgie;
Patientenaufnahme/*; Retrospektive Studien; Nutzungsüberprüfung
AB: BACKGROUND AND OBJECTIVE: Determination of inappropriate hospital use is of
G-AEP_Bericht_703.doc-22.08.2003-46